Bryan Haas, Pharm.D., M.S., R.Ph., is the Chief Clinical Research Officer at Ergomed Group where he leads the organization’s global clinical research organization, one that specializes in early phase studies and offers particular expertise in rare disease, head and neck, ovarian, and other oncology indications.
Bryan has spent more than 25 years in clinical research. He started in the CRO industry as a Clinical Research Associate and moved through project management and clinical operations into executive roles at PPD, PRA Health Sciences, and ICON, where he most recently served as Senior Vice President of ICON Commercialization and Outcomes Research.
Bryan has worked across therapeutic areas, including oncology, hematology and rare disease studies and across all phases of development. He has worked in compound partnering and with asset development teams, has experience with both adult and pediatric populations, and understands how to mitigate risk in the most complex studies that require rapid study start-up, robust supply chain and vendor management.
Mr. Haas holds a Pharm.D. and an M.S. in Health System Pharmacy Administration from the University of North Carolina at Chapel Hill.
